Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Cellular Health Screening Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Screening for breast and prostate cancer can significantly reduce an individual’s risk of dying
5.1.1.2. Increasing economic burden of chronic diseases
5.1.1.3. Increasing adoption of telomere performance programs
5.1.2. Restraints
5.1.2.1. Overdiagnosis is inevitability of screening leading to harmful consequences for people, including psychological distress, and incontinence
5.1.3. Opportunities
5.1.3.1. Rise in research activities, and a rapidly growing adoption of direct to customer approach
5.1.3.2. Rising government focus towards preventive healthcare
5.1.4. Challenges
5.1.4.1. High costs of screening and lack of resources in some economies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Cellular Health Screening Market, by Test Type
6.1. Introduction
6.2. Heavy Metal Tests
6.3. Inflammation Tests
6.4. Multi-Test Panels
6.5. Oxidative Stress Tests
6.6. Telomere Tests

7. Cellular Health Screening Market, by Sample Type
7.1. Introduction
7.2. Blood
7.3. Body Fluids

8. Americas Cellular Health Screening Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Cellular Health Screening Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Cellular Health Screening Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Cell Science Systems Corporation
12.1.2. Cell Signaling Technology, Inc.
12.1.3. Danaher Corp
12.1.4. Laboratory Corporation of America Holdings
12.1.5. Life Length S.L.
12.1.6. LifeVault Bio, Inc
12.1.7. Merck KGaA
12.1.8. OPKO Health, Inc.
12.1.9. PerkinElmer Inc.
12.1.10. Quest Diagnostics
12.1.11. Repeat Diagnostics, Inc.
12.1.12. SpectraCell Laboratories Inc
12.1.13. Thermo Fisher Scientific Inc.
12.1.14. Viome Life Sciences, Inc.
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. CELLULAR HEALTH SCREENING MARKET RESEARCH PROCESS
FIGURE 2. CELLULAR HEALTH SCREENING MARKET SIZE, 2023 VS 2030
FIGURE 3. CELLULAR HEALTH SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CELLULAR HEALTH SCREENING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CELLULAR HEALTH SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CELLULAR HEALTH SCREENING MARKET DYNAMICS
FIGURE 7. CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 8. CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
FIGURE 10. CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS CELLULAR HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS CELLULAR HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES CELLULAR HEALTH SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES CELLULAR HEALTH SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC CELLULAR HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC CELLULAR HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CELLULAR HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELLULAR HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. CELLULAR HEALTH SCREENING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. CELLULAR HEALTH SCREENING MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. CELLULAR HEALTH SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. CELLULAR HEALTH SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELLULAR HEALTH SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 6. CELLULAR HEALTH SCREENING MARKET SIZE, BY HEAVY METAL TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CELLULAR HEALTH SCREENING MARKET SIZE, BY INFLAMMATION TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CELLULAR HEALTH SCREENING MARKET SIZE, BY MULTI-TEST PANELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CELLULAR HEALTH SCREENING MARKET SIZE, BY OXIDATIVE STRESS TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CELLULAR HEALTH SCREENING MARKET SIZE, BY TELOMERE TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 12. CELLULAR HEALTH SCREENING MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CELLULAR HEALTH SCREENING MARKET SIZE, BY BODY FLUIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS CELLULAR HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 21. CANADA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 22. CANADA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 23. MEXICO CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 24. MEXICO CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES CELLULAR HEALTH SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC CELLULAR HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 32. AUSTRALIA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 33. CHINA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 34. CHINA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 35. INDIA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 36. INDIA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 38. INDONESIA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 39. JAPAN CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 40. JAPAN CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 42. MALAYSIA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 44. PHILIPPINES CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 46. SINGAPORE CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 48. SOUTH KOREA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 50. TAIWAN CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 51. THAILAND CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 52. THAILAND CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 54. VIETNAM CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA CELLULAR HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. DENMARK CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 59. DENMARK CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 60. EGYPT CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 61. EGYPT CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 62. FINLAND CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 63. FINLAND CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 64. FRANCE CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 65. FRANCE CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 66. GERMANY CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 67. GERMANY CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 69. ISRAEL CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 70. ITALY CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 71. ITALY CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 73. NETHERLANDS CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 75. NIGERIA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 76. NORWAY CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 77. NORWAY CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 78. POLAND CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 79. POLAND CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 80. QATAR CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 81. QATAR CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 88. SPAIN CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 89. SPAIN CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 91. SWEDEN CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 93. SWITZERLAND CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 94. TURKEY CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 95. TURKEY CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 100. CELLULAR HEALTH SCREENING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 101. CELLULAR HEALTH SCREENING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 102. CELLULAR HEALTH SCREENING MARKET LICENSE & PRICING